About APCI

APCI logo

Not a member?
Join today!

(800) 532-2724

Since 1984, APCI has been the ‘united voice of independent pharmacy’

APCI began as a small buying group for a limited number of independent pharmacies in central Alabama. Since that time, the cooperative has grown to more than 1,800 members pharmacies in 26 states, and provides its members with a wide range of products and services.

Our mission is to represent the economic and professional interests of independent pharmacies by providing leadership, vision, and a collective voice for our members in the healthcare marketplace. Our goal is to level the playing field for our member pharmacies by providing innovative, targeted programs to benefit our entire membership.

5

Jun

2017

CVS Caremark : ID Cards and DUR - Superior HealthPlan

Texas CHIP, STAR, STAR+PLUS, STAR Kids, STAR Health

Effective June 1, 2017, CVS Caremark began to process claims for Superior HealthPlan.

5

Jun

2017

Envolve Pharmacy Solutions - Medication Therapy Management (MTM) program

HIP Plus, Hoosier Care Connect and Hoosier Healthwise Medicaid MTM Program.

MHS invites you to become a preferred provider in its new Medication Therapy Management (MTM) program. To implement this program, MHS is collaborating with pharmacists to provide MTM services to a subgroup of patients enrolled in its HIP Plus, Hoosier Care Connect and Hoosier Healthwise Medicaid MTM Program.

5

Jun

2017

CVS Caremark : Kansas Medicaid - Sunflower Health Plan, Inc.

EFfective June 1, 2017

Envolve Pharmacy Solutions (formerly US Script) and CVS Caremark® are pleased to announce that effective June 1, 2017, CVS Caremark will begin to process claims for Sunflower Health Plan.

5

Jun

2017

PerformRx : First Choice VIP Care Plus - Removing Harvoni & Sovaldi from Part D Formulary

Effective August 1,2017

This letter is to inform you that as of August 1, 2017, Zepatier® and Epclusa® will be the First Choice VIP Care Plus (Medicare-Medicaid Plan) preferred formulary agents to treat Hepatitis C.

5

Jun

2017

Envolve : URGENT FDA NOTICE - Lupin Pharmaceuticals Recall of Mibela 24 Fe Tablets

Lupin Pharmaceuticals Inc. announced a recall of lot L600518, Exp 05/18 of Mibelas 24 Fe (Norethindrone Acetate and Ethinyl Estradiol 1 mg/0.02 mg chewable and ferrous fumarate 75 mg) Tablets at the consumer level.

First433435Last